Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia

Yu Zhang1, Norbert Schuff, Christopher Ching

  • 1Center for Imaging of Neurodegenerative Diseases, Department of Veterans Affairs San Francisco VA, Medical Center, 4150, Clement Street, San Francisco, CA 94121, USA.

Insights

This study reveals distinct MRI patterns in Alzheimer's disease (AD) and frontotemporal dementia (FTD). Joint analysis of brain structure and function offers new imaging markers for differentiating these neurodegenerative diseases.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Alzheimer's disease (AD) and frontotemporal dementia (FTD) are distinct neurodegenerative conditions.
  • Current MRI studies often analyze structural, perfusion, and diffusion abnormalities in isolation.
  • Understanding cross-modal MRI relationships is crucial for differential diagnosis.

Purpose of the Study:

  • To jointly assess gray matter (GM) and white matter (WM) abnormalities using multimodal MRI.
  • To elucidate differences in abnormal MRI patterns between AD and FTD.
  • To explore the potential of integrated MRI analysis for improved differential diagnosis.

Main Methods:

  • Utilized 4 Tesla MRI for high-resolution imaging.
  • Measured GM loss and hypoperfusion with T1-weighted and arterial spin labeling MRI (ASL-MRI).
  • Quantified WM degradation using diffusion tensor imaging (DTI).
  • Applied a novel analytical approach for joint assessment of multimodal data.

Main Results:

  • FTD exhibited greater white matter (WM) degeneration than AD at mild abnormality stages.
  • In FTD, gray matter (GM) loss and WM degeneration were more pronounced than perfusion deficits.
  • In AD, structural and functional brain damage showed similar severity.
  • Joint analysis revealed distinct patterns differentiating FTD and AD.

Conclusions:

  • Multimodal MRI analysis provides a more comprehensive understanding of AD and FTD pathologies.
  • Integrated assessment of GM, WM, and perfusion abnormalities can reveal disease-specific patterns.
  • Joint MRI assessments hold promise as novel imaging biomarkers for differentiating FTD from AD.

Related Concept Videos

Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...